Peer review reports
From: GBAP1 functions as a tumor promotor in hepatocellular carcinoma via the PI3K/AKT pathway
Original Submission | ||
---|---|---|
8 Oct 2022 | Submitted | Original manuscript |
Resubmission - Version 2 | ||
Submitted | Manuscript version 2 | |
Resubmission - Version 3 | ||
Submitted | Manuscript version 3 | |
16 Nov 2022 | Reviewed | Reviewer Report |
28 Nov 2022 | Reviewed | Reviewer Report - Binhui Xie |
14 Jan 2023 | Author responded | Author comments - Rong Chen |
Resubmission - Version 4 | ||
14 Jan 2023 | Submitted | Manuscript version 4 |
30 Jan 2023 | Author responded | Author comments - Rong Chen |
Resubmission - Version 5 | ||
30 Jan 2023 | Submitted | Manuscript version 5 |
3 Feb 2023 | Author responded | Author comments - Rong Chen |
Resubmission - Version 6 | ||
3 Feb 2023 | Submitted | Manuscript version 6 |
16 Feb 2023 | Author responded | Author comments - Rong Chen |
Resubmission - Version 7 | ||
16 Feb 2023 | Submitted | Manuscript version 7 |
7 Mar 2023 | Reviewed | Reviewer Report |
10 Mar 2023 | Reviewed | Reviewer Report - Binhui Xie |
11 Apr 2023 | Author responded | Author comments - Rong Chen |
Resubmission - Version 8 | ||
11 Apr 2023 | Submitted | Manuscript version 8 |
4 May 2023 | Reviewed | Reviewer Report |
Resubmission - Version 9 | ||
Submitted | Manuscript version 9 | |
Publishing | ||
23 Jun 2023 | Editorially accepted | |
5 Jul 2023 | Article published | 10.1186/s12885-023-11107-7 |